You have read all your free articles, to continue reading subscribe to read the rest of this content.
Recipharm has invested USD 450,000 into its Research Triangle Park (RTP), North Carolina, US facility to install a SprayVIEW system that will support inhalation and nasal product development. The newly acquired system was installed alongside an environmental controlled aerosol collection chamber Already a subscriber Login You have read all your…
Swedish Anocca has secured Venture Debt financing from the European Investment Bank (EIB). This significant investment recognizes the strength and high potential of Anocca and its transformational approach to developing T-cell therapies for cancer, the company states. "This financing supports usAlready a subscriber Login You have read all your free…
Gesynta Pharma has successfully raised SEK 190 million in one of the largest private biotech placements of the year in the Nordics. The placement was led by European life science fund manager Hadean Ventures, joined by existing investor Industrifonden and private funds. “We believe mPGES-1 iAlready a subscriber Login You…
The last patient has now been included in the ongoing clinical study with ACD440, the lead non-opioid drug candidate in the painless platform, which is being developed against peripheral neuropathic pain. This double-blind, placebo-controlled, randomized cross-over study, which is carried out in Already a subscriber Login You have read all…
